Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
27,615,000
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
6,330,423
-
Shares change
-
+167,911
-
Total reported value, excl. options
-
$1,930,752
-
Value change
-
+$60,644
-
Number of buys
-
5
-
Number of sells
-
-5
-
Price
-
$0.3050
Significant Holders of BiomX Inc. - Common stock, par value $0.0001 per share (PHGE) as of Q1 2023
15 filings reported holding PHGE - BiomX Inc. - Common stock, par value $0.0001 per share as of Q1 2023.
BiomX Inc. - Common stock, par value $0.0001 per share (PHGE) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6,330,423 shares
of 27,615,000 outstanding shares and own 23% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (3,161,489 shares), JOHNSON & JOHNSON (2,133,402 shares), MMCAP International Inc. SPC (608,162 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (195,598 shares), RENAISSANCE TECHNOLOGIES LLC (78,300 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (49,500 shares), MILLENNIUM MANAGEMENT LLC (33,266 shares), CITADEL ADVISORS LLC (30,475 shares), Walleye Capital LLC (21,056 shares), and Walleye Trading LLC (10,422 shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.